<DOC>
	<DOCNO>NCT03021811</DOCNO>
	<brief_summary>Multi-center , prospective , interventional , uncontrolled open-label study evaluate real-life use KLOX LumiHeal BioPhotonic System chronic wound management ( venous leg ulcer , diabetic foot ulcer , pressure ulcer ) .</brief_summary>
	<brief_title>EUREKA Italy - Evaluation Real-life Use KLOX BioPhotonic System Chronic Wounds Management</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Signed date write informed consent form ; Adult patient ( least 18 year old ) receive diagnosis venous leg ulcer , diabetic foot ulcer pressure ulcer Investigator ; The treating physician ( investigator ) believe KLOX LumiHeal BioPhotonic System would appropriate option ; Both male female patient must willing adhere medicallyaccepted birth control method course study ; Willingness comply study requirement ( visit , treatment , etc. ) . Female pregnant patient ( medical history ascertain pregnancy test ) ; Breastfeeding female patient ; Patients take drugs/products ( e.g. , methotrexate , chemotherapy agent ) condition ( e.g. , porphyria ) know induce severe photosensitivity reaction ; Patients know skin hypersensitivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>